 | • レポートコード：MRC2-11QY03069 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はベータ神経成長因子のグローバル市場について調査・分析したレポートです。種類別（KP-544、MEDI-7352、MT-2、MT-8、その他）市場規模、用途別（軽度認知障害、視神経損傷、鎌状赤血球症、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ベータ神経成長因子の競争状況、市場シェア ・世界のベータ神経成長因子市場：種類別市場規模 2015年-2020年（KP-544、MEDI-7352、MT-2、MT-8、その他） ・世界のベータ神経成長因子市場：種類別市場規模予測 2021年-2026年（KP-544、MEDI-7352、MT-2、MT-8、その他） ・世界のベータ神経成長因子市場：用途別市場規模 2015年-2020年（軽度認知障害、視神経損傷、鎌状赤血球症、その他） ・世界のベータ神経成長因子市場：用途別市場規模予測 2021年-2026年（軽度認知障害、視神経損傷、鎌状赤血球症、その他） ・北米のベータ神経成長因子市場分析：米国、カナダ ・ヨーロッパのベータ神経成長因子市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのベータ神経成長因子市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のベータ神経成長因子市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのベータ神経成長因子市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Astellas Pharma Inc、Fujimoto Pharmaceutical Corp、Krenitsky Pharmaceuticals Inc、MedImmune LLC、MimeTech Srl、Pfizer Inc、Regeneron Pharmaceuticals Inc、Serometrix LLC ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Beta Nerve Growth Factor Market
The global Beta Nerve Growth Factor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Beta Nerve Growth Factor Scope and Market Size
Beta Nerve Growth Factor market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Beta Nerve Growth Factor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Beta Nerve Growth Factor market is segmented into
KP-544
MEDI-7352
MT-2
MT-8
Others
Segment by Application, the Beta Nerve Growth Factor market is segmented into
Mild Congnitive Impairment
Optic Nerve Injury
Sickle Cell Disease
Others
Regional and Country-level Analysis
The Beta Nerve Growth Factor market is analysed and market size information is provided by regions (countries).
The key regions covered in the Beta Nerve Growth Factor market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Beta Nerve Growth Factor Market Share Analysis
Beta Nerve Growth Factor market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Beta Nerve Growth Factor business, the date to enter into the Beta Nerve Growth Factor market, Beta Nerve Growth Factor product introduction, recent developments, etc.
The major vendors covered:
Astellas Pharma Inc
Fujimoto Pharmaceutical Corp
Krenitsky Pharmaceuticals Inc
MedImmune LLC
MimeTech Srl
Pfizer Inc
Regeneron Pharmaceuticals Inc
Serometrix LLC
1 Study Coverage
1.1 Beta Nerve Growth Factor Product Introduction
1.2 Market Segments
1.3 Key Beta Nerve Growth Factor Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Beta Nerve Growth Factor Market Size Growth Rate by Type
1.4.2 KP-544
1.4.3 MEDI-7352
1.4.4 MT-2
1.4.5 MT-8
1.4.6 Others
1.5 Market by Application
1.5.1 Global Beta Nerve Growth Factor Market Size Growth Rate by Application
1.5.2 Mild Congnitive Impairment
1.5.3 Optic Nerve Injury
1.5.4 Sickle Cell Disease
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Beta Nerve Growth Factor Market Size, Estimates and Forecasts
2.1.1 Global Beta Nerve Growth Factor Revenue 2015-2026
2.1.2 Global Beta Nerve Growth Factor Sales 2015-2026
2.2 Global Beta Nerve Growth Factor, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Beta Nerve Growth Factor Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Beta Nerve Growth Factor Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Beta Nerve Growth Factor Competitor Landscape by Players
3.1 Beta Nerve Growth Factor Sales by Manufacturers
3.1.1 Beta Nerve Growth Factor Sales by Manufacturers (2015-2020)
3.1.2 Beta Nerve Growth Factor Sales Market Share by Manufacturers (2015-2020)
3.2 Beta Nerve Growth Factor Revenue by Manufacturers
3.2.1 Beta Nerve Growth Factor Revenue by Manufacturers (2015-2020)
3.2.2 Beta Nerve Growth Factor Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Beta Nerve Growth Factor Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Beta Nerve Growth Factor Revenue in 2019
3.2.5 Global Beta Nerve Growth Factor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Beta Nerve Growth Factor Price by Manufacturers
3.4 Beta Nerve Growth Factor Manufacturing Base Distribution, Product Types
3.4.1 Beta Nerve Growth Factor Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Beta Nerve Growth Factor Product Type
3.4.3 Date of International Manufacturers Enter into Beta Nerve Growth Factor Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Beta Nerve Growth Factor Market Size by Type (2015-2020)
4.1.1 Global Beta Nerve Growth Factor Sales by Type (2015-2020)
4.1.2 Global Beta Nerve Growth Factor Revenue by Type (2015-2020)
4.1.3 Beta Nerve Growth Factor Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Beta Nerve Growth Factor Market Size Forecast by Type (2021-2026)
4.2.1 Global Beta Nerve Growth Factor Sales Forecast by Type (2021-2026)
4.2.2 Global Beta Nerve Growth Factor Revenue Forecast by Type (2021-2026)
4.2.3 Beta Nerve Growth Factor Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Beta Nerve Growth Factor Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Beta Nerve Growth Factor Market Size by Application (2015-2020)
5.1.1 Global Beta Nerve Growth Factor Sales by Application (2015-2020)
5.1.2 Global Beta Nerve Growth Factor Revenue by Application (2015-2020)
5.1.3 Beta Nerve Growth Factor Price by Application (2015-2020)
5.2 Beta Nerve Growth Factor Market Size Forecast by Application (2021-2026)
5.2.1 Global Beta Nerve Growth Factor Sales Forecast by Application (2021-2026)
5.2.2 Global Beta Nerve Growth Factor Revenue Forecast by Application (2021-2026)
5.2.3 Global Beta Nerve Growth Factor Price Forecast by Application (2021-2026)
6 North America
6.1 North America Beta Nerve Growth Factor by Country
6.1.1 North America Beta Nerve Growth Factor Sales by Country
6.1.2 North America Beta Nerve Growth Factor Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Beta Nerve Growth Factor Market Facts & Figures by Type
6.3 North America Beta Nerve Growth Factor Market Facts & Figures by Application
7 Europe
7.1 Europe Beta Nerve Growth Factor by Country
7.1.1 Europe Beta Nerve Growth Factor Sales by Country
7.1.2 Europe Beta Nerve Growth Factor Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Beta Nerve Growth Factor Market Facts & Figures by Type
7.3 Europe Beta Nerve Growth Factor Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Beta Nerve Growth Factor by Region
8.1.1 Asia Pacific Beta Nerve Growth Factor Sales by Region
8.1.2 Asia Pacific Beta Nerve Growth Factor Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Beta Nerve Growth Factor Market Facts & Figures by Type
8.3 Asia Pacific Beta Nerve Growth Factor Market Facts & Figures by Application
9 Latin America
9.1 Latin America Beta Nerve Growth Factor by Country
9.1.1 Latin America Beta Nerve Growth Factor Sales by Country
9.1.2 Latin America Beta Nerve Growth Factor Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Beta Nerve Growth Factor Market Facts & Figures by Type
9.3 Central & South America Beta Nerve Growth Factor Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Beta Nerve Growth Factor by Country
10.1.1 Middle East and Africa Beta Nerve Growth Factor Sales by Country
10.1.2 Middle East and Africa Beta Nerve Growth Factor Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Beta Nerve Growth Factor Market Facts & Figures by Type
10.3 Middle East and Africa Beta Nerve Growth Factor Market Facts & Figures by Application
11 Company Profiles
11.1 Astellas Pharma Inc
11.1.1 Astellas Pharma Inc Corporation Information
11.1.2 Astellas Pharma Inc Description and Business Overview
11.1.3 Astellas Pharma Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Astellas Pharma Inc Beta Nerve Growth Factor Products Offered
11.1.5 Astellas Pharma Inc Related Developments
11.2 Fujimoto Pharmaceutical Corp
11.2.1 Fujimoto Pharmaceutical Corp Corporation Information
11.2.2 Fujimoto Pharmaceutical Corp Description and Business Overview
11.2.3 Fujimoto Pharmaceutical Corp Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Fujimoto Pharmaceutical Corp Beta Nerve Growth Factor Products Offered
11.2.5 Fujimoto Pharmaceutical Corp Related Developments
11.3 Krenitsky Pharmaceuticals Inc
11.3.1 Krenitsky Pharmaceuticals Inc Corporation Information
11.3.2 Krenitsky Pharmaceuticals Inc Description and Business Overview
11.3.3 Krenitsky Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Krenitsky Pharmaceuticals Inc Beta Nerve Growth Factor Products Offered
11.3.5 Krenitsky Pharmaceuticals Inc Related Developments
11.4 MedImmune LLC
11.4.1 MedImmune LLC Corporation Information
11.4.2 MedImmune LLC Description and Business Overview
11.4.3 MedImmune LLC Sales, Revenue and Gross Margin (2015-2020)
11.4.4 MedImmune LLC Beta Nerve Growth Factor Products Offered
11.4.5 MedImmune LLC Related Developments
11.5 MimeTech Srl
11.5.1 MimeTech Srl Corporation Information
11.5.2 MimeTech Srl Description and Business Overview
11.5.3 MimeTech Srl Sales, Revenue and Gross Margin (2015-2020)
11.5.4 MimeTech Srl Beta Nerve Growth Factor Products Offered
11.5.5 MimeTech Srl Related Developments
11.6 Pfizer Inc
11.6.1 Pfizer Inc Corporation Information
11.6.2 Pfizer Inc Description and Business Overview
11.6.3 Pfizer Inc Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Pfizer Inc Beta Nerve Growth Factor Products Offered
11.6.5 Pfizer Inc Related Developments
11.7 Regeneron Pharmaceuticals Inc
11.7.1 Regeneron Pharmaceuticals Inc Corporation Information
11.7.2 Regeneron Pharmaceuticals Inc Description and Business Overview
11.7.3 Regeneron Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Regeneron Pharmaceuticals Inc Beta Nerve Growth Factor Products Offered
11.7.5 Regeneron Pharmaceuticals Inc Related Developments
11.8 Serometrix LLC
11.8.1 Serometrix LLC Corporation Information
11.8.2 Serometrix LLC Description and Business Overview
11.8.3 Serometrix LLC Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Serometrix LLC Beta Nerve Growth Factor Products Offered
11.8.5 Serometrix LLC Related Developments
11.1 Astellas Pharma Inc
11.1.1 Astellas Pharma Inc Corporation Information
11.1.2 Astellas Pharma Inc Description and Business Overview
11.1.3 Astellas Pharma Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Astellas Pharma Inc Beta Nerve Growth Factor Products Offered
11.1.5 Astellas Pharma Inc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Beta Nerve Growth Factor Market Estimates and Projections by Region
12.1.1 Global Beta Nerve Growth Factor Sales Forecast by Regions 2021-2026
12.1.2 Global Beta Nerve Growth Factor Revenue Forecast by Regions 2021-2026
12.2 North America Beta Nerve Growth Factor Market Size Forecast (2021-2026)
12.2.1 North America: Beta Nerve Growth Factor Sales Forecast (2021-2026)
12.2.2 North America: Beta Nerve Growth Factor Revenue Forecast (2021-2026)
12.2.3 North America: Beta Nerve Growth Factor Market Size Forecast by Country (2021-2026)
12.3 Europe Beta Nerve Growth Factor Market Size Forecast (2021-2026)
12.3.1 Europe: Beta Nerve Growth Factor Sales Forecast (2021-2026)
12.3.2 Europe: Beta Nerve Growth Factor Revenue Forecast (2021-2026)
12.3.3 Europe: Beta Nerve Growth Factor Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Beta Nerve Growth Factor Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Beta Nerve Growth Factor Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Beta Nerve Growth Factor Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Beta Nerve Growth Factor Market Size Forecast by Region (2021-2026)
12.5 Latin America Beta Nerve Growth Factor Market Size Forecast (2021-2026)
12.5.1 Latin America: Beta Nerve Growth Factor Sales Forecast (2021-2026)
12.5.2 Latin America: Beta Nerve Growth Factor Revenue Forecast (2021-2026)
12.5.3 Latin America: Beta Nerve Growth Factor Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Beta Nerve Growth Factor Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Beta Nerve Growth Factor Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Beta Nerve Growth Factor Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Beta Nerve Growth Factor Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Beta Nerve Growth Factor Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Beta Nerve Growth Factor Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Beta Nerve Growth Factor Market Segments
Table 2. Ranking of Global Top Beta Nerve Growth Factor Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Beta Nerve Growth Factor Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of KP-544
Table 5. Major Manufacturers of MEDI-7352
Table 6. Major Manufacturers of MT-2
Table 7. Major Manufacturers of MT-8
Table 8. Major Manufacturers of Others
Table 9. Global Beta Nerve Growth Factor Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Beta Nerve Growth Factor Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Beta Nerve Growth Factor Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Beta Nerve Growth Factor Sales Market Share by Regions (2015-2020)
Table 13. Global Beta Nerve Growth Factor Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Beta Nerve Growth Factor Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Beta Nerve Growth Factor Sales Share by Manufacturers (2015-2020)
Table 16. Global Beta Nerve Growth Factor Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Beta Nerve Growth Factor by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Beta Nerve Growth Factor as of 2019)
Table 18. Beta Nerve Growth Factor Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Beta Nerve Growth Factor Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Beta Nerve Growth Factor Price (2015-2020) (USD/Pcs)
Table 21. Beta Nerve Growth Factor Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Beta Nerve Growth Factor Product Type
Table 23. Date of International Manufacturers Enter into Beta Nerve Growth Factor Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Beta Nerve Growth Factor Sales by Type (2015-2020) (K Pcs)
Table 26. Global Beta Nerve Growth Factor Sales Share by Type (2015-2020)
Table 27. Global Beta Nerve Growth Factor Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Beta Nerve Growth Factor Revenue Share by Type (2015-2020)
Table 29. Beta Nerve Growth Factor Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Beta Nerve Growth Factor Sales by Application (2015-2020) (K Pcs)
Table 31. Global Beta Nerve Growth Factor Sales Share by Application (2015-2020)
Table 32. North America Beta Nerve Growth Factor Sales by Country (2015-2020) (K Pcs)
Table 33. North America Beta Nerve Growth Factor Sales Market Share by Country (2015-2020)
Table 34. North America Beta Nerve Growth Factor Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Beta Nerve Growth Factor Revenue Market Share by Country (2015-2020)
Table 36. North America Beta Nerve Growth Factor Sales by Type (2015-2020) (K Pcs)
Table 37. North America Beta Nerve Growth Factor Sales Market Share by Type (2015-2020)
Table 38. North America Beta Nerve Growth Factor Sales by Application (2015-2020) (K Pcs)
Table 39. North America Beta Nerve Growth Factor Sales Market Share by Application (2015-2020)
Table 40. Europe Beta Nerve Growth Factor Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Beta Nerve Growth Factor Sales Market Share by Country (2015-2020)
Table 42. Europe Beta Nerve Growth Factor Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Beta Nerve Growth Factor Revenue Market Share by Country (2015-2020)
Table 44. Europe Beta Nerve Growth Factor Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Beta Nerve Growth Factor Sales Market Share by Type (2015-2020)
Table 46. Europe Beta Nerve Growth Factor Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Beta Nerve Growth Factor Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Beta Nerve Growth Factor Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Beta Nerve Growth Factor Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Beta Nerve Growth Factor Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Beta Nerve Growth Factor Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Beta Nerve Growth Factor Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Beta Nerve Growth Factor Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Beta Nerve Growth Factor Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Beta Nerve Growth Factor Sales Market Share by Application (2015-2020)
Table 56. Latin America Beta Nerve Growth Factor Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Beta Nerve Growth Factor Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Beta Nerve Growth Factor Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Beta Nerve Growth Factor Revenue Market Share by Country (2015-2020)
Table 60. Latin America Beta Nerve Growth Factor Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Beta Nerve Growth Factor Sales Market Share by Type (2015-2020)
Table 62. Latin America Beta Nerve Growth Factor Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Beta Nerve Growth Factor Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Beta Nerve Growth Factor Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Beta Nerve Growth Factor Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Beta Nerve Growth Factor Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Beta Nerve Growth Factor Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Beta Nerve Growth Factor Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Beta Nerve Growth Factor Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Beta Nerve Growth Factor Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Beta Nerve Growth Factor Sales Market Share by Application (2015-2020)
Table 72. Astellas Pharma Inc Corporation Information
Table 73. Astellas Pharma Inc Description and Major Businesses
Table 74. Astellas Pharma Inc Beta Nerve Growth Factor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Astellas Pharma Inc Product
Table 76. Astellas Pharma Inc Recent Development
Table 77. Fujimoto Pharmaceutical Corp Corporation Information
Table 78. Fujimoto Pharmaceutical Corp Description and Major Businesses
Table 79. Fujimoto Pharmaceutical Corp Beta Nerve Growth Factor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Fujimoto Pharmaceutical Corp Product
Table 81. Fujimoto Pharmaceutical Corp Recent Development
Table 82. Krenitsky Pharmaceuticals Inc Corporation Information
Table 83. Krenitsky Pharmaceuticals Inc Description and Major Businesses
Table 84. Krenitsky Pharmaceuticals Inc Beta Nerve Growth Factor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Krenitsky Pharmaceuticals Inc Product
Table 86. Krenitsky Pharmaceuticals Inc Recent Development
Table 87. MedImmune LLC Corporation Information
Table 88. MedImmune LLC Description and Major Businesses
Table 89. MedImmune LLC Beta Nerve Growth Factor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. MedImmune LLC Product
Table 91. MedImmune LLC Recent Development
Table 92. MimeTech Srl Corporation Information
Table 93. MimeTech Srl Description and Major Businesses
Table 94. MimeTech Srl Beta Nerve Growth Factor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. MimeTech Srl Product
Table 96. MimeTech Srl Recent Development
Table 97. Pfizer Inc Corporation Information
Table 98. Pfizer Inc Description and Major Businesses
Table 99. Pfizer Inc Beta Nerve Growth Factor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Pfizer Inc Product
Table 101. Pfizer Inc Recent Development
Table 102. Regeneron Pharmaceuticals Inc Corporation Information
Table 103. Regeneron Pharmaceuticals Inc Description and Major Businesses
Table 104. Regeneron Pharmaceuticals Inc Beta Nerve Growth Factor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Regeneron Pharmaceuticals Inc Product
Table 106. Regeneron Pharmaceuticals Inc Recent Development
Table 107. Serometrix LLC Corporation Information
Table 108. Serometrix LLC Description and Major Businesses
Table 109. Serometrix LLC Beta Nerve Growth Factor Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. Serometrix LLC Product
Table 111. Serometrix LLC Recent Development
Table 112. Global Beta Nerve Growth Factor Sales Forecast by Regions (2021-2026) (K Pcs)
Table 113. Global Beta Nerve Growth Factor Sales Market Share Forecast by Regions (2021-2026)
Table 114. Global Beta Nerve Growth Factor Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 115. Global Beta Nerve Growth Factor Revenue Market Share Forecast by Regions (2021-2026)
Table 116. North America: Beta Nerve Growth Factor Sales Forecast by Country (2021-2026) (K Pcs)
Table 117. North America: Beta Nerve Growth Factor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 118. Europe: Beta Nerve Growth Factor Sales Forecast by Country (2021-2026) (K Pcs)
Table 119. Europe: Beta Nerve Growth Factor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 120. Asia Pacific: Beta Nerve Growth Factor Sales Forecast by Region (2021-2026) (K Pcs)
Table 121. Asia Pacific: Beta Nerve Growth Factor Revenue Forecast by Region (2021-2026) (US$ Million)
Table 122. Latin America: Beta Nerve Growth Factor Sales Forecast by Country (2021-2026) (K Pcs)
Table 123. Latin America: Beta Nerve Growth Factor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 124. Middle East and Africa: Beta Nerve Growth Factor Sales Forecast by Country (2021-2026) (K Pcs)
Table 125. Middle East and Africa: Beta Nerve Growth Factor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 127. Key Challenges
Table 128. Market Risks
Table 129. Main Points Interviewed from Key Beta Nerve Growth Factor Players
Table 130. Beta Nerve Growth Factor Customers List
Table 131. Beta Nerve Growth Factor Distributors List
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Beta Nerve Growth Factor Product Picture
Figure 2. Global Beta Nerve Growth Factor Sales Market Share by Type in 2020 & 2026
Figure 3. KP-544 Product Picture
Figure 4. MEDI-7352 Product Picture
Figure 5. MT-2 Product Picture
Figure 6. MT-8 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Beta Nerve Growth Factor Sales Market Share by Application in 2020 & 2026
Figure 9. Mild Congnitive Impairment
Figure 10. Optic Nerve Injury
Figure 11. Sickle Cell Disease
Figure 12. Others
Figure 13. Beta Nerve Growth Factor Report Years Considered
Figure 14. Global Beta Nerve Growth Factor Market Size 2015-2026 (US$ Million)
Figure 15. Global Beta Nerve Growth Factor Sales 2015-2026 (K Pcs)
Figure 16. Global Beta Nerve Growth Factor Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Beta Nerve Growth Factor Sales Market Share by Region (2015-2020)
Figure 18. Global Beta Nerve Growth Factor Sales Market Share by Region in 2019
Figure 19. Global Beta Nerve Growth Factor Revenue Market Share by Region (2015-2020)
Figure 20. Global Beta Nerve Growth Factor Revenue Market Share by Region in 2019
Figure 21. Global Beta Nerve Growth Factor Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Beta Nerve Growth Factor Revenue in 2019
Figure 23. Beta Nerve Growth Factor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Beta Nerve Growth Factor Sales Market Share by Type (2015-2020)
Figure 25. Global Beta Nerve Growth Factor Sales Market Share by Type in 2019
Figure 26. Global Beta Nerve Growth Factor Revenue Market Share by Type (2015-2020)
Figure 27. Global Beta Nerve Growth Factor Revenue Market Share by Type in 2019
Figure 28. Global Beta Nerve Growth Factor Market Share by Price Range (2015-2020)
Figure 29. Global Beta Nerve Growth Factor Sales Market Share by Application (2015-2020)
Figure 30. Global Beta Nerve Growth Factor Sales Market Share by Application in 2019
Figure 31. Global Beta Nerve Growth Factor Revenue Market Share by Application (2015-2020)
Figure 32. Global Beta Nerve Growth Factor Revenue Market Share by Application in 2019
Figure 33. North America Beta Nerve Growth Factor Sales Growth Rate 2015-2020 (K Pcs)
Figure 34. North America Beta Nerve Growth Factor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Beta Nerve Growth Factor Sales Market Share by Country in 2019
Figure 36. North America Beta Nerve Growth Factor Revenue Market Share by Country in 2019
Figure 37. U.S. Beta Nerve Growth Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. U.S. Beta Nerve Growth Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Beta Nerve Growth Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. Canada Beta Nerve Growth Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Beta Nerve Growth Factor Market Share by Type in 2019
Figure 42. North America Beta Nerve Growth Factor Market Share by Application in 2019
Figure 43. Europe Beta Nerve Growth Factor Sales Growth Rate 2015-2020 (K Pcs)
Figure 44. Europe Beta Nerve Growth Factor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Beta Nerve Growth Factor Sales Market Share by Country in 2019
Figure 46. Europe Beta Nerve Growth Factor Revenue Market Share by Country in 2019
Figure 47. Germany Beta Nerve Growth Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Germany Beta Nerve Growth Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Beta Nerve Growth Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. France Beta Nerve Growth Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Beta Nerve Growth Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. U.K. Beta Nerve Growth Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Beta Nerve Growth Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Italy Beta Nerve Growth Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Beta Nerve Growth Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Russia Beta Nerve Growth Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Beta Nerve Growth Factor Market Share by Type in 2019
Figure 58. Europe Beta Nerve Growth Factor Market Share by Application in 2019
Figure 59. Asia Pacific Beta Nerve Growth Factor Sales Growth Rate 2015-2020 (K Pcs)
Figure 60. Asia Pacific Beta Nerve Growth Factor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Beta Nerve Growth Factor Sales Market Share by Region in 2019
Figure 62. Asia Pacific Beta Nerve Growth Factor Revenue Market Share by Region in 2019
Figure 63. China Beta Nerve Growth Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. China Beta Nerve Growth Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Beta Nerve Growth Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Beta Nerve Growth Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Beta Nerve Growth Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. South Korea Beta Nerve Growth Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Beta Nerve Growth Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. India Beta Nerve Growth Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Beta Nerve Growth Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Australia Beta Nerve Growth Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Beta Nerve Growth Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Taiwan Beta Nerve Growth Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Beta Nerve Growth Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Indonesia Beta Nerve Growth Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Beta Nerve Growth Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Thailand Beta Nerve Growth Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Beta Nerve Growth Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Malaysia Beta Nerve Growth Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Beta Nerve Growth Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Philippines Beta Nerve Growth Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Beta Nerve Growth Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Vietnam Beta Nerve Growth Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Beta Nerve Growth Factor Market Share by Type in 2019
Figure 86. Asia Pacific Beta Nerve Growth Factor Market Share by Application in 2019
Figure 87. Latin America Beta Nerve Growth Factor Sales Growth Rate 2015-2020 (K Pcs)
Figure 88. Latin America Beta Nerve Growth Factor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Beta Nerve Growth Factor Sales Market Share by Country in 2019
Figure 90. Latin America Beta Nerve Growth Factor Revenue Market Share by Country in 2019
Figure 91. Mexico Beta Nerve Growth Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Mexico Beta Nerve Growth Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Beta Nerve Growth Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Brazil Beta Nerve Growth Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Beta Nerve Growth Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Argentina Beta Nerve Growth Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Beta Nerve Growth Factor Market Share by Type in 2019
Figure 98. Latin America Beta Nerve Growth Factor Market Share by Application in 2019
Figure 99. Middle East and Africa Beta Nerve Growth Factor Sales Growth Rate 2015-2020 (K Pcs)
Figure 100. Middle East and Africa Beta Nerve Growth Factor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Beta Nerve Growth Factor Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Beta Nerve Growth Factor Revenue Market Share by Country in 2019
Figure 103. Turkey Beta Nerve Growth Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Turkey Beta Nerve Growth Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Beta Nerve Growth Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Saudi Arabia Beta Nerve Growth Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Beta Nerve Growth Factor Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. U.A.E Beta Nerve Growth Factor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Beta Nerve Growth Factor Market Share by Type in 2019
Figure 110. Middle East and Africa Beta Nerve Growth Factor Market Share by Application in 2019
Figure 111. North America Beta Nerve Growth Factor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. North America Beta Nerve Growth Factor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Beta Nerve Growth Factor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Europe Beta Nerve Growth Factor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Beta Nerve Growth Factor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Asia Pacific Beta Nerve Growth Factor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Beta Nerve Growth Factor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Latin America Beta Nerve Growth Factor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Beta Nerve Growth Factor Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Middle East and Africa Beta Nerve Growth Factor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed
高親和性神経成長因子受容体の世界市場（～2026年） Market Analysis and Insights: Global High Affinity Nerve Growth Factor Receptor Market The global High Affinity Nerve Growth Factor Receptor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global High Affinity Nerve Growth Fa…- トランスフォーミンググロースファクターベータ2の世界市場（～2026年） Market Analysis and Insights: Global Transforming Growth Factor Beta 2 Market The global Transforming Growth Factor Beta 2 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Transforming Growth Factor Beta 2 Scope and Mar…
- 核因子カッパBキナーゼサブユニットベータ阻害剤の世界市場（～2026年） Market Analysis and Insights: Global Inhibitor of Nuclear Factor Kappa B Kinase Subunit Beta Market The global Inhibitor of Nuclear Factor Kappa B Kinase Subunit Beta market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Inh…
- 視神経膠腫の世界市場（～2026年） An optic nerve glioma is a type of brain tumor. There are multiple kinds of brain tumors. Typically, each type of tumor is named after the kinds of cells it affects. Most optic nerve gliomas are considered low-grade and don’t grow as quickly as other types of brain tumors. They are found in the opti…
- 神経修復の世界市場（～2026年） Neuroregeneration refers to the regrowth or repair of nervous tissues, cells or cell products. Such mechanisms may include generation of new neurons, glia, axons, myelin, or synapses. Neuroregeneration differs between the peripheral nervous system (PNS) and the central nervous system (CNS) by the fu…